Kratom Research Institute

Research · 2026-08-17

Kratom's Main Alkaloid Reduced Methamphetamine-Seeking in Rats, Study Finds

Source: Kratom.news (reporting on Psychopharmacology study)

Why it matters

With no FDA-approved medication for methamphetamine use disorder, early evidence that a kratom-derived alkaloid can selectively reduce drug-seeking behavior, without blunting motivation for food, points to a possible treatment lead worth further study.

The big picture

The Psychopharmacology study arrives amid a broader research effort separating kratom's dominant leaf alkaloid, mitragynine, from 7-hydroxymitragynine (7-OH), the more potent, opioid-receptor-binding metabolite driving most current regulatory and enforcement action, including an NIDA-supported Phase 1 human trial of purified mitragynine (MG001) now weeks from its first dose.

Key findings

What they say

"Mitragynine reduced methamphetamine-seeking in rats while leaving food-maintained responding intact, behavioral selectivity in an animal model, not evidence of a treatment in people," the researchers said, per the Rutgers Brain Health Institute summary.

Bottom line

**A purified kratom alkaloid cut meth-seeking behavior in rats without dulling their drive to eat, a preclinical signal worth testing further, not a reason to self-treat with kratom.**